Ziprasidone: efficacy and safety in patients with bipolar disorder.
about
Ziprasidone in the treatment of mania in bipolar disorder.QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadineCharacterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.Improved ziprasidone formulations with enhanced bioavailability in the fasted state and a reduced food effect.Preparation and evaluation of ziprasidone-phospholipid complex from sustained-release pellet formulation with enhanced bioavailability and no food effect.
P2860
Ziprasidone: efficacy and safety in patients with bipolar disorder.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Ziprasidone: efficacy and safety in patients with bipolar disorder.
@ast
Ziprasidone: efficacy and safety in patients with bipolar disorder.
@en
type
label
Ziprasidone: efficacy and safety in patients with bipolar disorder.
@ast
Ziprasidone: efficacy and safety in patients with bipolar disorder.
@en
prefLabel
Ziprasidone: efficacy and safety in patients with bipolar disorder.
@ast
Ziprasidone: efficacy and safety in patients with bipolar disorder.
@en
P2860
P1476
Ziprasidone: efficacy and safety in patients with bipolar disorder.
@en
P2093
Nick C Patel
Paul E Keck
P2860
P304
P356
10.1586/14737175.6.8.1129
P577
2006-08-01T00:00:00Z